Ligne de temps

Cécile Artaud
Chef(fe) de Projet
01 Jan 2022
publication

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.

Lire plus
01 Jan 2021
publication

Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome.

Lire plus
25 Apr 2019
news

Recrutement de patients piqués par une tique pouvant participer à l’étude OHTICKS

Lire plus
04 Dec 2018
publication

A multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project)

Lire plus
12 Oct 2018
project

CoSImmGEn-F : constitution d’une cohorte de sujets atteints de polypose adénomateuse familiale et porteurs d’une mutation du gène APC afin d’étudier le rôle de la génétique du système immunitaire et de l’environnement dans la maladie

Lire plus
14 Jul 2017
publication

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial

Lire plus
20 Dec 2016
publication

Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate

Lire plus
27 Mar 2016
project

A synthetic carbohydrate-based conjugate vaccine ready for a clinical trial

Lire plus
04 Feb 2016
publication

The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity

Lire plus
30 Sep 2015
project

A synthetic glycopeptide for anti-tumor immunotherapy: from design to first use in human

Lire plus
15 Sep 2015
project

Clinical development of cancer vaccines

Lire plus